Cargando…
Treatment of Complicated Henoch-Schönlein Purpura with Mycophenolate Mofetil: A Retrospective Case Series Report
Background. Henoch-Schönlein purpura (HSP) is the most common childhood vasculitis with an incidence of approximately 10 per 100 000 children. There is some evidence to support steroid therapy in the treatment of severe abdominal pain, severe nephritis, and central nervous system involvement. Howeve...
Autores principales: | Nikibakhsh, A. A., Mahmoodzadeh, H., Karamyyar, M., Hejazi, S., Noroozi, M., Macooie, A. A., Gholizadeh, A., Gholizadeh, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901604/ https://www.ncbi.nlm.nih.gov/pubmed/20628492 http://dx.doi.org/10.1155/2010/254316 |
Ejemplares similares
-
Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
por: Nickavar, Azar, et al.
Publicado: (2017) -
Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011) -
Gastrointestinal Henoch–Schönlein purpura successfully treated with Mycophenolate Mofetil: Description of 2 case reports
por: Gicchino, Maria Francesca, et al.
Publicado: (2021) -
Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis
por: Malekinejad, H., et al.
Publicado: (2012) -
Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis
por: Lu, Zhihong, et al.
Publicado: (2017)